Secondary monoclonal antibodies · 01. July 2025

LO‑ME‑3, a rat anti-mouse IgE monoclonal antibody developed and manufactured by SynAbs, is a high-affinity reagent for in vitro R&D use only (RUO). It is validated in dozens of peer-reviewed studies as a core tool in allergy, asthma, and immunoassay workflows.

Secondary monoclonal antibodies · 06. May 2025

Looking for a rat anti-mouse IgM antibody for your next ELISA or immunoassay? LO-MM-3 by SynAbs is a high-affinity, RUO-grade monoclonal antibody trusted in murine immunology research. Ideal for in vitro diagnostics, B-cell assays, and antibody profiling, LO-MM-3 delivers consistency, specificity, and performance. Order LO-MM-3 today to power your next research-only immunoassay.

New primary monoclonal antibodies · 23. April 2025

SYnAbs RUO monoclonal antibodies of mouse and rat species highly specific to Estradiol without cross-reactivity to close steroid analogs

New primary monoclonal antibodies · 16. April 2025

SYnAbs unique R&D and therapeutic monoclonal antibodies to CCR10 (GPR-2), C-C chemokine Receptor 10 GPCR transmembrane protein

New primary monoclonal antibodies · 10. April 2025

Valproic acid (VPA) is a widely used drug with narrow therapeutic window, necessitating precise monitoring of blood levels to avoid toxicity or sub-therapeutic effects. Traditional methods of measuring VPA have limitations in terms of sensitivity, specificity, and accuracy. In this context, SYnAbs has developed the best monoclonal antibodies against VPA.